PatientPartner
United States
- San Diego , CA
- 05/09/2024
- Seed
- $7,000,000
PatientPartner is a digital health platform that leverages the power of real-world patient experiences to personalize the patient journey and drive market awareness for pharmaceutical and medical device companies.
✅ With PatientPartner, 85% of patients who connect with a peer about their options move forward with treatment
✅ With PatientPartner, our customers see an average of an
18% Average Script Lift paired with a 25% decrease in patient adherence drop off rate.
✅ On PatientPartner platform there are over 30,000+ patients, 100,000+ connections and over 500+ Patient Ambassadors who are daily active users.
✅ PatientPartner is HIPPA & SOC 2 Compliance approved with several of the largest healthcare organizations in the world.
✅ We provide the ability to show full circle data attribution on your direct-to-patient marketing initiatives.
✅ Our proprietary patent pending algorithm is able to connect patients to experienced mentors based on relatability which is proven to increase overall patient satisfaction with their treatment.
- Industry Consumer Services
- Website https://patientpartner.com/
- LinkedIn https://www.linkedin.com/company/patientpartner/
Related People
George KrambCo Founder
United States -
San Diego County, California
My personal goal is to leave the world better than where I found it. As the Cofounder and CEO of PatientPartner, I want to provide patients the ability to learn from one another and bring true connectivity to the patient community.
I believe accessibility is the greatest asset one can give, so drop me a note and I'll be sure to respond.
Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)